Jason Pitofsky - Aug 7, 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
VP Controller
Signature
/s/**Jason Pitofsky
Stock symbol
REGN
Transactions as of
Aug 7, 2024
Transactions value $
-$339,702
Form type
4
Date filed
8/7/2024, 04:40 PM
Previous filing
Feb 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $181K +487 +11.58% $372.46 4.69K Aug 7, 2024 Direct
transaction REGN Common Stock Sale -$521K -487 -10.38% $1,070.00 4.2K Aug 7, 2024 Direct
holding REGN Common Stock 10 Aug 7, 2024 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -487 -100% $0.00* 0 Aug 7, 2024 Common Stock 487 $372.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option award vests in four equal annual installments, commencing one year after the date of grant.